Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a cultural and medical shift. I ...

Ro and LifeMD said they would offer access to all doses of the drug - which is a stronger version of Ozempic - for $499 ... but all people have to do via telehealth platforms is make an online ...

Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

For everything that was wrong about WeightWatchers, once upon a time it did something right. It tapped into the power of ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

While effective, Ozempic's health risks, regulatory challenges, and cultural impact ... Ozempic and Wegovy are prescription-only medications, but telehealth services and online pharmacies have ...

U.S. District Judge Mark Pittman in Texas denied compounders' bid for a preliminary injunction, according to the court docket. Pittman filed his legal reasoning under seal, but by denying the ...

Weight loss company WeightWatchers has filed for Chapter 11 bankruptcy protection after falling $1.15 billion into debt. The ...